- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Revenues Increase 111% Year-Over-Year, Quarterly Net Income of $0.10 Per Share
Tegal Corporation (Nasdaq:TGAL), a leading designer and manufacturer of plasma etch and deposition systems used in the production of integrated circuits and nanotechnology devices, today announced financial results for the Second Quarter Fiscal Year 2008, which ended September 30, 2007. Senior management will conduct an investor conference call to discuss these results and the company's financial outlook in more detail today at 2:00 p.m. Pacific Time, Tuesday, November 6, 2007. More information about the conference call is provided below.
Second Quarter Highlights
* Net income of $693 thousand or $0.10 per share compared to a net loss of ($3.3) million in the same period last year and ($639) thousand in the prior quarter.
* Operating income reached $1.1 million during the quarter excluding non-cash charges of $0.6 million.
* Shipments during the quarter included 3 advanced etch systems for high volume manufacturing of integrated active-passive devices in Europe and an advanced PVD system to a leading European analog and power device manufacturer.
* The Company announced new orders for 900 and 980 etch systems and upgrades from a leading hard disk drive manufacturer and a leading Japan-based sensor and control systems maker.
"We are pleased to report our first quarterly profit since December 2000, a very significant milestone," said Thomas Mika, President and CEO of Tegal Corporation. "We have made substantial progress in the strategic re-engineering of our business, improving our overall cost structure and delivering sales growth, while continuing to work towards driving new product introductions. This quarter we remained focused on manufacturing and also field support for the many advanced systems that we have recently delivered. We are also making good progress in our efforts to complete and place tools with customers for our new products, including the AMS PVD tool for Aluminum Nitride applications, our innovative NLD product, and the porting of our etch technology onto our new Compact platform. We are very pleased with our accomplishments so far, but feel we can still drive more improvements in our business and continue to deliver improved operating results."
Revenues for the second quarter of fiscal 2008 were $10.8 million, an increase of 111% from the $5.1 million in the same period last year. Tegal reported net income of $0.7 million, or $0.10 per share, for the quarter, compared to a net loss of ($3.3) million, or ($0.47) per share in the same period last year, and a net loss of ($0.6) million, or ($0.09) per share in the prior quarter.
Gross profits for the second quarter of fiscal 2008 were 39.3% compared to 46.9% in the same period last year, but up from the 35.3% in the prior quarter.
Operating income for the second quarter was $0.5 million, including approximately $0.6 million of non-cash charges. This was an improvement over the $3.1 million operating loss in the same period last year and the $1.4 million operating loss in the prior quarter, which included $0.5 million and $0.6 million of non-cash charges, respectively.
Backlog was $8.9M at the end of the quarter.
$18.5 million remains in a Litigation Suspense liability account, pending resolution of the company's dispute with its attorneys over the amount payable under the settlement agreement. The $1 million reduction in the account reflects a settlement of $995 thousand with one of the attorneys representing Sputtered Films, Inc.
Cash at the end of the fiscal second quarter of 2008 was $20.3 million, a $5.4 million decrease from the end of the March quarter. Over the same 6 month period, inventories increased by $5.5 million to $11.1 million, while accounts payable increased by $1.9 million to $3.4 million, both reflecting the investment required to fulfill orders coming in during the quarter.
Investor Conference Call
Tegal Corporation will discuss these results and further details of its second quarter of fiscal 2008 during a conference call today, November 6, 2007, at 5:00 p.m. EST / 2:00 p.m. PST. The call is open to all interested investors. The call-in numbers are (866) 578-5771 or (617) 213-8055. For either dial-in number, Investors should reference passcode: 98159631. A digital recording will be made available two hours after the completion of the conference call, and it will be accessible through midnight on Tuesday, November 13, 2007. To access, investors should dial (888) 286-8010 or (617) 801-6888 and enter passcode: 31764338. The conference call also will be available online via the Investor Section of the Company's website at: www.tegal.com. An online replay of the teleconference, along with a copy of the Company's earnings release, will also be available on the Company's website.
Safe Harbor Statement
Except for historical information, matters discussed in this news release contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements, which are based on assumptions and describe our future plans, strategies and expectations, are generally identifiable by the use of the words "anticipate," "believe," "estimate," "expect," "intend," "project" or similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions about the Company including, but not limited to industry conditions, economic conditions, acceptance of new technologies and market acceptance of the Company's products and services. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements in this paragraph. For a further discussion of these risks and uncertainties, please refer to the Company's periodic filings with the Securities and Exchange Commission.
About Tegal Corporation
Tegal provides process and equipment solutions to leading edge suppliers of advanced semiconductor and nanotechnology devices. Incorporating unique, patented etch and deposition technologies, Tegal’s system solutions are backed by over 35 years of advanced development and over 100 patents. Some examples of devices enabled by Tegal technology are energy efficient memories found in portable computers, cellphones, PDAs and RFID applications; megapixel imaging chips used in digital and cellphone cameras; power amplifiers for portable handsets and wireless networking gear; and MEMS devices like accelerometers for automotive airbags, microfluidic control devices for ink jet printers; and laboratory-on-a-chip medical test kits.
More information is available on the Internet at: www.tegal.com.
TEGAL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
|Sept 30||March 31|
|Cash and cash equivalents||$||20,348||$||25,776|
|Accounts receivable, net of allowances for sales returns and doubtful accounts of $230 and $413 at September 30, 2007 and March 31, 2007, respectively||8,056||6,634|
|Prepaid expenses and other current assets||1,497||991|
|Total current assets||41,079||38,968|
|Property and equipment, net||1,318||1,351|
|Intangible assets, net||1,026||1,161|
|LIABILITIES AND STOCKHOLDERS’ EQUITY|
|Notes payable and bank lines of credit||$||—||$||10|
|Accrued product warranty||1,435||1,101|
|Accrued expenses and other current liabilities||3,228||3,590|
|Total current liabilities||28,193||27,239|
|Total long term liabilities||—||—|
|Commitments and contingencies (Note 7)|
|Preferred stock; $0.01 par value; 5,000,000 shares authorized; none issued and outstanding||—||—|
|Common stock; $0.01 par value; 50,000,000 shares authorized; 7,126,912 and 7,106,867 shares issued and outstanding at September 30, 2007 and March 31, 2007, respectively||71||71|
|Additional paid-in capital||123,281||122,473|
|Accumulated other comprehensive income (loss)||297||240|
|Total stockholders’ equity||15,337||14,417|
|Total liabilities and stockholders’ equity||$||43,530||$||41,656|
TEGAL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Three Months Ended
Six Months Ended
|Cost of sales||6,560||2,713||9,537||6,791|
|Research and development expenses||1,057||1,066||1,835||2,062|
|Sales and marketing expenses||1,279||964||2,285||2,008|
|General and administrative expenses||1,448||3,485||2,651||5,787|
|Total operating expenses||3,784||5,515||6,771||9,857|
|Other income (expense), net||237||(166||)||964||(124||)|
|Net loss per share, basic and diluted||$||0.10||$||(0.47||)||$||0.01||$||(0.72||)|
|Shares used in per share computation:|
Note: Shares used in per share computation for Basic and Diluted reflect a 1 to 12 reverse stock split effected by the Company on July 25, 2006
For more information, please click here
Christine Hergenrother, 707-763-5600 (VP and CFO)
The Blue Shirt Group
Rakesh Mehta or Chris Danne, 415-217-7722
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Argon is not the 'dope' for metallic hydrogen March 24th, 2017
Electro-optical switch transmits data at record-low temperatures: Operating at temperatures near absolute zero, switch could enable significantly faster data processing with lower power consumption March 20th, 2017
Argon is not the 'dope' for metallic hydrogen March 24th, 2017
Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017
Next-gen steel under the microscope March 18th, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016